Delivery Order SPE2DR25D2006-SPE2DR26F56ZN
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,336.81 to AmerisourceBergen Drug Corp for the supply of Spravato 84 mg dose pack UDS (unit dose system). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of December 8, 2025, and represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Spravato 84 mg dose pack units of use, valued at $11,134.62 on October 24, 2025, with an ultimate completion date of October 27, 2025. This is a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,625.24 to AmerisourceBergen Drug Corp for Spravato 56 mg dose pack unit dose system (UDS) pharmaceutical products. This competitive, non-set-aside contract was awarded on December 22, 2025, with an ultimate completion date of December 23, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Spravato is a specialized nasal spray medication used in the treatment of major...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,829.09 to AmerisourceBergen Drug Corp for the supply of SPRAVATO 84 mg dose pack UDS (unit dose packages). This firm fixed price delivery order, awarded on July 28, 2025, with an ultimate completion date of July 29, 2025, represents a non-competitive set-aside contract and will be performed at the contractor's facility in Conshohocken, Pennsylvania. SPRAVATO (esketamine) is a prescription nasal spray used in treating...
- The Defense Logistics Agency awarded a $6,361 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562252303, described as 84 mg dose packs of Spravato. Spravato is an esketamine nasal spray used to treat treatment-resistant depression and suicidal thoughts. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The period of performance is September 20-21, 2023. No set aside designation or subcontractors are identified. The Defense...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division to provide SPRAVATO 84 MG DOSE PACK UDS, a pharmaceutical product, for a firm fixed price of $4,959.80. This contract has an ultimate completion date of June 25, 2024. Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, fulfills this delivery order as part of a larger Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,860.83 firm-fixed-price delivery order is for SPRAVATO 84 MG DOSE PACK UDS, a medication, with an ultimate completion date of July 11, 2025. This contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,005.06 firm fixed-price delivery order is for the supply of SPRAVATO 84 MG DOSE PACK medical product, with an ultimate completion date of October 30, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,134.70 contract is for the delivery of SPRAVATO 84 MG DOSE PACK UDS, a specialty pharmaceutical product. The award is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of SPRAVATO 84 MG DOSE PACK UDS, a medical product, with a ceiling value of $8,812.72. The contract is a firm-fixed price delivery order with a completion date of June 9, 2025. This award is not associated with a set-aside program, indicating open competition. AmerisourceBergen Drug Corp...
- SPE2DR25D2006Indefinite Delivery Contract
- SPE2DR25D2006-SPE2DR26F56ZNDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,238.82 to AmerisourceBergen Drug Corp for Spravato 84 mg dose pack unit dose systems (UDS) on December 26, 2025, with a completion date of December 29, 2025. This firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was competitively selected to fulfill this requirement through its existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 through December 2026. Spravato (esketamine) is a nasal spray medication used primarily for treatment-resistant depression and is typically delivered through specialized healthcare settings. This delivery order represents one of numerous pharmaceutical supply transactions AmerisourceBergen Drug Corp executes with the DLA's Medical Supply Chain to support military and federal healthcare systems. The company's portfolio of federal contracts spans diverse therapeutic categories including neurological treatments, pain management, diabetes medications, and vaccines, demonstrating its critical role in ensuring continuous pharmaceutical supply to the Defense Health Agency and other federal healthcare beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.2k | 12/25/25 |